Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corp (symbol: DDD) is a pioneer in the 3D printing industry, offering a broad array of 3D printing and digital manufacturing solutions. The company's product portfolio includes 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. With over 35 years of experience, 3D Systems is at the forefront of innovation in additive manufacturing, impacting a wide range of industries from healthcare and dental to aerospace, automotive, and durable goods.
3D Systems' operations are segmented into Healthcare Solutions and Industrial Solutions, with a significant portion of its revenue generated from the Industrial segment. The company has a strong global presence with offices and facilities across the Americas, EMEA, and APAC regions, although the majority of its revenue comes from the Americas.
The company's recent projects have showcased its advanced capabilities in both industrial and healthcare applications. For instance, 3D Systems has pioneered a first-to-market solution for jetted, monolithic dentures, combining bespoke materials to deliver high-performance dental prosthetics. This innovation has gained interest from leading dental labs and is expected to receive FDA clearance in the second half of 2024.
On the industrial front, 3D Systems continues to expand its portfolio. Recently, the company has seen growth in its metal 3D printing division with Wilting, an industrial machining and metal 3D printing service provider, adding multiple DMP Flex 350 metal 3D printers to its production line. This expansion will enable Wilting to meet increasing customer demand more efficiently.
Financially, 3D Systems has been proactive in managing its liabilities and maintaining a strong balance sheet. The company recently entered into repurchase agreements to buy back $110 million of its 0% Convertible Senior Notes due 2026, thereby reducing its outstanding debt significantly.
3D Systems' commitment to innovation is further exemplified by its developments in patient-specific medical devices. The FDA recently cleared its VSP® PEEK Cranial Implant solution, designed for use in cranioplasty procedures, which utilizes additive manufacturing to produce highly customized, cost-effective cranial implants.
Looking ahead, 3D Systems aims to harness its leadership in digital dentistry, with plans to expand its product offerings to include night guards and direct-printed clear aligners. The company has also secured a multi-year purchase agreement, valued at nearly a quarter-billion dollars, to support the indirect manufacturing process for clear aligners, a testament to its robust 3D printing technology and market leadership.
3D Systems' unique combination of hardware, software, materials, and services, powered by expert application engineers, ensures they continue to transform industries and empower their customers to innovate. More information on 3D Systems is available at www.3dsystems.com.
3D Systems' subsidiary, Oqton, has achieved significant adoption of its AI-driven Manufacturing Operating System, with several hundred dental labs utilizing the platform in its first 18 months. The system enhances production efficiency by over 50% and boasts a strong customer renewal rate, indicated by negative churn rates of 20-30%. The lifetime-value to customer-acquisition-cost ratio exceeds 5, showcasing substantial value creation. Oqton’s AI technology efficiently integrates with a variety of OEM production equipment, facilitating a seamless workflow in diverse manufacturing settings. Bertram Dental Lab, a leading RPD manufacturer, reported a 50%+ efficiency increase since adopting Oqton. The software's potential extends to other sectors, including healthcare and industrial markets, suggesting future growth opportunities for 3D Systems.
3D Systems (NYSE:DDD) has confirmed the successful verification of mechanical properties for NASA's new laser powder bed fusion super alloy, GRX-810. This innovative alloy is designed for aerospace applications, showcasing exceptional strength, ductility, heat resistance, and creep life.
Using its Direct Metal Printing platform, 3D Systems processed and tested GRX-810, marking a significant milestone for materials in aerospace components. These properties present opportunities to replace traditional nickel-based super alloys in critical engine parts.
Dr. Michael Shepard from 3D Systems emphasized the potential of GRX-810 and the company’s commitment to advancing additive manufacturing in aerospace.
The University Hospital of Salzburg has successfully performed a groundbreaking surgery using a 3D-printed PEEK cranial implant for a patient suffering from skull deformity. This significant advancement utilized 3D Systems' Kumovis R1 printer and Oqton's D2P and Geomagic Freeform software to create a patient-specific implant. With the cranial implants market projected to exceed $2 billion by 2030, this innovation positions 3D Systems favorably within a rapidly growing sector. The PEEK material utilized is lightweight and mimics the mechanical properties of bone, enhancing patient comfort. The successful application of these technologies demonstrates the potential for improved orthopedic outcomes in personalized healthcare.
3D Systems (NYSE: DDD) announced it will release its first quarter 2023 financial results after the U.S. markets close on May 8, 2023. The company will host a conference call to discuss these results on May 9, 2023, at 8:30 a.m. Eastern Time. Investors can join the discussion via webcast or by telephone at 201-689-8345. A replay of the call will be available about two hours after its conclusion. 3D Systems continues to position itself as a leader in additive manufacturing, servicing markets such as healthcare, automotive, and aerospace with its innovative solutions.
Systemic Bio, a subsidiary of 3D Systems (NYSE:DDD), has announced the opening of a new 15,000 sq. ft. facility in Houston's TMC Innovation Factory Labs. This state-of-the-art location is dedicated to the R&D and production of the h-VIOS™ organ-on-a-chip platform, which allows for the testing of pharmaceutical drugs using human cells. The facility features cleanroom manufacturing to support sterile production and aims to fulfill multiple contracts with pharmaceutical companies over the next year. Jeremy Carter joins as Vice President of Operations to oversee this new venture, which marks a significant milestone in Systemic Bio’s drug discovery initiatives.
3D Systems (NYSE: DDD) has partnered with TE Connectivity to develop an innovative additive manufacturing solution for producing electrical connectors that meet stringent UL regulatory standards. The collaboration introduces a novel photopolymer that allows for production within weeks, significantly reducing lead times compared to traditional methods. This first-ever UL-recognized photopolymer has passed long-term thermal aging tests, displaying exceptional properties such as a flammability rating of UL94 V0 at 0.4mm thickness. With this new technology, TE Connectivity can efficiently produce complex geometries and adapt to low-volume production demands, enhancing its competitive edge in the market.
3D Systems announced major enhancements to its digital dentistry portfolio with the introduction of innovative materials, NextDent Base and NextDent Cast, designed for improved mechanical properties. The NextDent LCD1 printer, a compact and user-friendly device, is now available, enabling clinics to adopt 3D printing to enhance efficiency and patient experience. NextDent Base is a third-generation denture base material with high break resistance and aesthetic options, while NextDent Cast offers easy burn-out features for various dental applications. These products aim to streamline workflows and improve results in dental practices.